Michael J. Schell
Reproducibility track record
1
assessed papers
97/100
mean reproducibility
1
reproduced (C1–C2)
0
flagged
0
total citations
flag rate:
0%
(0/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 0
last author: 0
Topics
—
Funders
—
Frequent co-authors
Yong Chen 1Christian Schlein 1Jöerg Heeren 1Joschka J. Buyel 1Franziska Siegel 1Jennifer Naumann 1Kirsi A. Virtanen 1Mark J. W. Hanssen 1Alexander Pfeifer 1Anouk van der Lans 1
Institutions
University of Bonn 1University Hospital Bonn 1University Medical Center 1Maastricht University 1Universität Hamburg 1University Medical Center Hamburg-Eppendorf 1
Geography (author institutions)
DE 1US 1NL 1FI 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (345)
Request a reproduction →1 assessed by us (1 reproduced) · 344 not yet assessed — every PubMed paper on record, linked below.
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Myosteatosis and Sarcopenic Obesity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Rationale for Mechanism-Driven Multimodal Intervention ↗Preprints.org · 2026not yet assessed
-
Abstract 6126: Multiomics integration unveils a shifted balance in the sphingosine-1 phosphate/ceramide rheostat fueled by macrophage immunosuppression in metastatic colorectal cancer ↗Cancer Research · 2026not yet assessed
-
Myosteatosis and Sarcopenic Obesity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Rationale for Mechanism-Driven Multimodal Intervention ↗Cancers · 2026 · PMID 42073599not yet assessed
-
Multidimensional LDCT Imaging Endpoints for a Randomized Pilot Phase II Trial of Curcumin and Omega-3 Fatty Acids for Lung Cancer Chemoprevention: Results of a Randomized Pilot Trial ↗Cancers · 2026 · PMID 42649879not yet assessed
-
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial ↗Nature Communications · 2026 · PMID 42185255not yet assessed
-
Identifying distinct prognostic and predictive contributions of tumor epithelium versus tumor microenvironment in colorectal cancer ↗BMC Cancer · 2025 · PMID 40075322not yet assessed
-
Persistence and clearance of oral human papillomavirus among a multi-national cohort of men ↗Nature Communications · 2025 · PMID 41044066not yet assessed
-
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer ↗Clinical Cancer Research · 2025 · PMID 41117857not yet assessed
-
A Retrospective Cohort Study of Physical Activity and Survival in Patients Treated with Immune Checkpoint Inhibitors ↗Cancer Epidemiology Biomarkers & Prevention · 2025 · PMID 40971247not yet assessed
-
Nutritional intake of ω-3 fatty acid intake and clinical grade of prostate cancer ↗Cancer Epidemiology · 2025 · PMID 41223508not yet assessed
-
Updated efficacy, safety, and correlative analysis of a phase II trial in metastatic renal cell carcinoma with coordinated pembrolizumab and high dose IL-2. ↗Journal of Clinical Oncology · 2025not yet assessed
-
Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial ↗American Journal of Clinical Oncology · 2025 · PMID 40905435not yet assessed
-
Pembrolizumab plus High-Dose IL-2 in Advanced Clear Cell Renal Cell Carcinoma: Six-Year Survival Outcomes and Molecular Signatures from a Phase 2 Trial ↗Research Square · 2025not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Abstract 2: Oral HPV Prevalence and Genotypes Among Men Living with HIV in Latin America and the Caribbean: Preliminary Results of the ULACNet-201 Trial ↗Cancer Epidemiology Biomarkers & Prevention · 2025not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Determining the threshold time in restricted mean survival time analysis for two group comparisons with applications in clinical and epidemiology studies ↗American Journal of Epidemiology · 2025 · PMID 39968729not yet assessed
-
Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer ↗Gut · 2024 · PMID 39658263not yet assessed
-
Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors ↗ESMO Open · 2024 · PMID 38507897not yet assessed
-
Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma ↗Clinical Cancer Research · 2024 · PMID 39417680not yet assessed
-
Multinational epidemiological analysis of oral human papillomavirus incidence in 3,137 men ↗Nature Microbiology · 2024 · PMID 39424983not yet assessed
-
Identification of a Biomarker Panel from Genome-Wide Methylation to Detect Early HPV-Associated Oropharyngeal Cancer ↗Cancer Prevention Research · 2024 · PMID 38286404not yet assessed
-
First-in-human study of 225actinium mti-201 (225Ac-MTI-201) in metastatic uveal melanoma (UM). ↗Journal of Clinical Oncology · 2024not yet assessed
-
A phase II trial of AZD1775 plus carboplatin-paclitaxel in squamous cell lung cancer (SqCLC). ↗Journal of Clinical Oncology · 2024not yet assessed
-
not yet assessed
-
High-resolution transcriptional signature to predict survival benefit in colorectal cancer (CRC) treated with EGFR inhibitors (EGFRi) independent of RAS/BRAF mutation status or tumor sidedness. ↗Journal of Clinical Oncology · 2024not yet assessed
-
APC as a high-utility mutational biomarker that may identify subpopulations of patients with mutant RAS/BRAF and right-sided colorectal cancer (CRC) who derive benefit from EGFR inhibitors (EGFRi). ↗Journal of Clinical Oncology · 2024not yet assessed
-
External validation of the ARCAD nomogram in a real-world cohort of patients with stage IV colorectal cancer (CRC). ↗Journal of Clinical Oncology · 2024not yet assessed
-
Expanded Antigen-Specific Donor Regulatory T Cells for Gvhd Prevention ↗Transplantation and Cellular Therapy · 2024 · PMID 42322116not yet assessed
-
Abstract 6430: Gene expression signature quantifies the cellular contribution of the tumor vs. the microenvironment in determining colorectal cancer prognosis and therapeutic outcome ↗Cancer Research · 2024not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Identification of Biomarkers that May Extend the Utility of Anti EGFR Therapies to Subpopulations of Right-Sided and Mutant RAS Metastatic Colorectal Cancer ↗SSRN Electronic Journal · 2024not yet assessed
-
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer ↗International Journal of Radiation Oncology*Biology*Physics · 2023 · PMID 36657497not yet assessed
-
Techniques to produce and evaluate realistic multivariate synthetic data ↗Scientific Reports · 2023 · PMID 37507387not yet assessed
-
Safety outcomes of pembrolizumab with platinum agent chemotherapy combined with 5-fluorouracil or taxane derivative in head and neck cancer ↗Journal of Oncology Pharmacy Practice · 2023 · PMID 38043938not yet assessed
-
SARS-CoV-2 antibody response duration and neutralization following natural infection ↗Journal of Clinical Virology Plus · 2023 · PMID 37654784not yet assessed
-
Feasibility of an Evolutionary Tumor Board for Generating Novel Personalized Therapeutic Strategies ↗Research Square · 2023not yet assessed
-
Feasibility of an Evolutionary Tumor Board for Generating Novel Personalized Therapeutic Strategies ↗medRxiv · 2023not yet assessed
-
A multicenter phase II study of vaccines to prevent recurrence in patients with HER-2–positive breast cancer. ↗Journal of Clinical Oncology · 2023not yet assessed
-
20-year incidence trends of anal squamous cell carcinoma. ↗Journal of Clinical Oncology · 2023not yet assessed
-
not yet assessed
-
not yet assessed
-
Supplementary Data from Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas ↗2023not yet assessed
-
not yet assessed
-
Supplementary Data from Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas ↗2023not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma ↗Clinical Cancer Research · 2022 · PMID 36215121not yet assessed
-
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma ↗Journal for ImmunoTherapy of Cancer · 2022 · PMID 35676062not yet assessed
-
Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer ↗Targeted Oncology · 2022 · PMID 35767139not yet assessed
-
An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy ↗BMC Cancer · 2022 · PMID 35272617not yet assessed
-
Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal Cancer ↗Clinical Genitourinary Cancer · 2022 · PMID 35249821not yet assessed
-
Natural History of Incident and Persistent Cutaneous Human Papillomavirus and Human Polyomavirus Infections ↗The Journal of Infectious Diseases · 2022 · PMID 35022780not yet assessed
-
Abstract 1239: Prognostic and predictive value of PIK3CA mutations in metastatic CRC (mCRC) ↗Cancer Research · 2022not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
not yet assessed
-
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer ↗British Journal of Cancer · 2021 · PMID 33828254not yet assessed
-
Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study ↗Cancers · 2021 · PMID 33803335not yet assessed
-
Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas ↗Cancer Research · 2021 · PMID 34266893not yet assessed
-
APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes ↗Cancers · 2021 · PMID 34771559not yet assessed
-
Tumor immune infiltration estimated from gene expression profiles predicts colorectal cancer relapse ↗OncoImmunology · 2021 · PMID 33763292not yet assessed
-
Integrative Analysis Identifies Multi-Omics Signatures That Drive Molecular Classification of Uveal Melanoma ↗Cancers · 2021 · PMID 34944787not yet assessed
-
Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal Excision ↗Clinical Colorectal Cancer · 2021 · PMID 33775560not yet assessed
-
Association between Human Polyomaviruses and Keratinocyte Carcinomas: A Prospective Cohort Study ↗Cancer Epidemiology Biomarkers & Prevention · 2021 · PMID 34187857not yet assessed
-
Evidence-based Target Recall Rates for Screening Mammography 1 ↗Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2021not yet assessed
-
Prospective Phase I/II Study of Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable NSCLC ↗International Journal of Radiation Oncology*Biology*Physics · 2021not yet assessed
-
Techniques to Produce and Evaluate Realistic Multivariate Synthetic Data ↗bioRxiv (Cold Spring Harbor Laboratory) · 2021not yet assessed
-
Efficacy of concurrent cetuximab (CTX) and nivolumab (NIVO) in previously untreated recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). ↗Journal of Clinical Oncology · 2021not yet assessed
-
Results of biomarker analysis from phase II trial of nivolumab in refractory biliary tract cancer. ↗Journal of Clinical Oncology · 2021not yet assessed
-
not yet assessed
-
Impact of Tumor Dosimetry on Clinical Outcomes after Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma ↗International Journal of Radiation Oncology*Biology*Physics · 2021not yet assessed
-
Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation ↗Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2021not yet assessed
-
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer ↗JAMA Oncology · 2020 · PMID 32352498not yet assessed
-
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLC ↗Journal of Thoracic Oncology · 2020 · PMID 33301984not yet assessed
-
Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer ↗International Journal of Radiation Oncology*Biology*Physics · 2020 · PMID 33002543not yet assessed
-
A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy ↗Oncotarget · 2020 · PMID 32292572not yet assessed
-
Cutaneous viral infections associated with ultraviolet radiation exposure ↗International Journal of Cancer · 2020 · PMID 32818302not yet assessed
-
Modeling precision genomic-based radiation dose response in rectal cancer ↗Future Oncology · 2020 · PMID 32686956not yet assessed
-
Concurrent cetuximab (CTX) and nivolumab (NIVO) in patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of phase II study. ↗Journal of Clinical Oncology · 2020not yet assessed
-
Optimizing Clinical Outcome and Toxicity in Lung Cancer Using a Genomic Marker of Radiosensitivity ↗medRxiv · 2020not yet assessed
-
A Favorable Effect of Higher Ambient Temperature on COVID-19 Deaths in the USA ↗SSRN Electronic Journal · 2020not yet assessed
-
APC and TP53 as potential biomarkers for EGFR sensitivity in colorectal cancer. ↗Journal of Clinical Oncology · 2020not yet assessed
-
Assessment of Treatment Cost-effectiveness Using a Colorectal Cancer Mutation Profile ↗JAMA Network Open · 2020 · PMID 32150267not yet assessed
-
Abstract B41: BRAF targeting sensitizes resistant melanoma to cytotoxic T cells ↗Cancer Immunology Research · 2020not yet assessed
-
Predictors of recurrence and implications for overall survival in borderline resectable pancreatic cancer patients treated with total neoadjuvant therapy: A retrospective cohort study. ↗Journal of Clinical Oncology · 2020not yet assessed
-
P-47 A phase I/II study of pembrolizumab in combination with ibrutinib for advanced, refractory microsatellite stable colorectal cancers ↗Annals of Oncology · 2020not yet assessed
-
Abstract 5789: A novel role of APC-partnering mutations in the sidedness of colorectal cancer survival ↗Cancer Research · 2020not yet assessed
-
Need for More Comprehensive Evaluation of Immune-Related Adverse Events in Immunotherapy for Biliary Tract Cancer—Reply ↗JAMA Oncology · 2020 · PMID 33090188not yet assessed
-
Impact of the SARS-COV-2 Pandemic on the Pediatric Homecare Unit ActivityPediatric Blood & Cancer · 2020not yet assessed
-
The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy ↗Clinical Cancer Research · 2019 · PMID 31399473not yet assessed
-
Completion of adjuvant therapy in patients with resected pancreatic cancer ↗HPB · 2019 · PMID 31563326not yet assessed
-
BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells ↗Clinical Cancer Research · 2019 · PMID 30765391not yet assessed
-
Methylation of HPV 16 and EPB41L3 in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics ↗International Journal of Cancer · 2019 · PMID 31304592not yet assessed
-
Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance ↗British Journal of Cancer · 2019 · PMID 30880334not yet assessed
-
Repurposing EGFR Inhibitor Utility in Colorectal Cancer in Mutant APC and TP53 Subpopulations ↗Cancer Epidemiology Biomarkers & Prevention · 2019 · PMID 31015202not yet assessed
-
A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms ↗Neuroendocrinology · 2019 · PMID 31357193not yet assessed
-
Gate-tunable optical filter based on conducting oxide metasurface heterostructure ↗Optics Letters · 2019 · PMID 31368935not yet assessed
-
A Prospective Single Arm Phase I/II Study: Consolidative Ipilimumab and Nivolumab with Thoracic Radiotherapy after Platinum Based Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer ↗International Journal of Radiation Oncology*Biology*Physics · 2019not yet assessed
-
A phase II study of nivolumab in patients with advanced refractory biliary tract cancers (BTC). ↗Journal of Clinical Oncology · 2019not yet assessed
-
Overall responses with coordinated pembrolizumab and high dose IL-2 (5-in-a-row schedule) for therapy of metastatic clear cell renal cancer: A single center, single arm trial. ↗Journal of Clinical Oncology · 2019not yet assessed
-
Phase II study of ibrutinib in advanced carcinoid and pancreatic neuroendocrine tumors. ↗Journal of Clinical Oncology · 2019not yet assessed
-
Abstract 3170: BRAF expression is associated with poor survival in colorectal cancers independent of BRAF (V600E) mutation ↗Cancer Research · 2019not yet assessed
-
Integrated profiling the patterns of pathologic response to neoadjuvant chemoradiation and the genomic-based radiation sensitivity in rectal cancer. ↗Journal of Clinical Oncology · 2019not yet assessed
-
Abstract 3170:BRAFexpression is associated with poor survival in colorectal cancers independent ofBRAF(V600E) mutation ↗Clinical Research (Excluding Clinical Trials) · 2019not yet assessed
-
Beyond Blind Dose-Escalation: Modeling Precision Genomic-Based Radiation Dose-Response In Rectal Cancer ↗International Journal of Radiation Oncology*Biology*Physics · 2019not yet assessed
-
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity ↗SSRN Electronic Journal · 2019not yet assessed
-
Clinical associations of mucin 1 in human lung cancer and precancerous lesions ↗Oncotarget · 2018 · PMID 30479696not yet assessed
-
A Phase II multi institutional study of nivolumab in patients with advanced refractory biliary tract cancers (BTC) ↗Annals of Oncology · 2018not yet assessed
-
PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation ↗Scientific Reports · 2018 · PMID 29915291not yet assessed
-
Cutaneous Viral Infections Across 2 Anatomic Sites Among a Cohort of Patients Undergoing Skin Cancer Screening ↗The Journal of Infectious Diseases · 2018 · PMID 30260406not yet assessed
-
Empirically-Derived Synthetic Populations to Mitigate Small Sample Sizes ↗bioRxiv (Cold Spring Harbor Laboratory) · 2018not yet assessed
-
Molecular rationale for ERK and EGFR inhibition in colorectal cancer. ↗Journal of Clinical Oncology · 2018not yet assessed
-
Abstract 2571: An integral genomic/expression analysis reveals a cooperative role of APC and TP53 mutations in identifying cetuximab-sensitive colorectal cancer ↗Cancer Research · 2018not yet assessed
-
Identification of mutation biomarkers underpinning colon cancer sidedness and cetuximab sensitivity. ↗Journal of Clinical Oncology · 2018not yet assessed
-
Worauf kommt es an, wenn die Maschine in die USA geliefert wird? ↗Konstruktion · 2018not yet assessed
-
Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach ↗Oncotarget · 2017 · PMID 28423681not yet assessed
-
Tumour radiosensitivity is associated with immune activation in solid tumours ↗European Journal of Cancer · 2017 · PMID 28863385not yet assessed
-
Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer ↗Journal of Surgical Oncology · 2017 · PMID 28833197not yet assessed
-
SinCHet: a MATLAB toolbox for single cell heterogeneity analysis in cancer ↗Bioinformatics · 2017 · PMID 28472395not yet assessed
-
Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer ↗Oncotarget · 2017 · PMID 29228755not yet assessed
-
A phase I trial of panobinostat with ipilimumab in advanced melanoma. ↗Journal of Clinical Oncology · 2017not yet assessed
-
P2.01-072 Clinical Associations of MUC1 Expression in Human Lung Cancer and Precancerous Lesions ↗Journal of Thoracic Oncology · 2017not yet assessed
-
Skin homing and highly suppressive (CD45RA−CD27−) Tregs associated with ultraviolet radiation exposure ↗The Journal of Immunology · 2017not yet assessed
-
A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study ↗The Lancet Oncology · 2016 · PMID 27993569not yet assessed
-
Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab ↗Cancer Immunology Research · 2016 · PMID 26873574not yet assessed
-
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC ↗Nature Communications · 2016 · PMID 27302369not yet assessed
-
Exosomal microRNA miR-92a concentration in serum reflects human brown fat activityNature Communications · 2016 · PMID 27117818L1 97/100
-
Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins ↗Oncotarget · 2016 · PMID 28053292not yet assessed
-
The tumour suppressor CYLD regulates the p53 DNA damage response ↗Nature Communications · 2016 · PMID 27561390not yet assessed
-
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer ↗The Oncologist · 2016 · PMID 27694157not yet assessed
-
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer ↗BMC Medical Genomics · 2016 · PMID 27756306not yet assessed
-
E4 ligase–specific ubiquitination hubs coordinate DNA double-strand-break repair and apoptosis ↗Nature Structural & Molecular Biology · 2016 · PMID 27669035not yet assessed
-
Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors ↗Bone Marrow Transplantation · 2016 · PMID 27991896not yet assessed
-
A Genomic Framework for Precision Radiation Therapy ↗International Journal of Radiation Oncology*Biology*Physics · 2016not yet assessed
-
Additional file 1: of Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer ↗Figshare · 2016not yet assessed
-
Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention ↗Cancer Prevention Research · 2015 · PMID 25873370not yet assessed
-
β-Arrestin-1 Mediates Nicotine-Induced Metastasis through E2F1 Target Genes That Modulate Epithelial–Mesenchymal Transition ↗Cancer Research · 2015 · PMID 25600647not yet assessed
-
Both tumor depth and diameter are predictive of sentinel lymph node status and survival in M erkel cell carcinoma ↗Cancer · 2015 · PMID 26038193not yet assessed
-
Regulation of the DNA damage response by ubiquitin conjugation ↗Frontiers in Genetics · 2015 · PMID 25806049not yet assessed
-
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma ↗Oral Oncology · 2015 · PMID 25593015not yet assessed
-
Co-Evolution of Somatic Variation in Primary and Metastatic Colorectal Cancer May Expand Biopsy Indications in the Molecular Era ↗PLoS ONE · 2015 · PMID 25974029not yet assessed
-
A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome ↗Clinical Cancer Research · 2015 · PMID 26446941not yet assessed
-
Effect of Age on Clinical Outcomes in Phase 1 Trial Participants ↗Cancer Control · 2015 · PMID 26068771not yet assessed
-
Survival, biomarker, and toxicity analysis of nivolumab (NIVO) in patients that progressed on ipilimumab (IPI). ↗Journal of Clinical Oncology · 2015not yet assessed
-
Abstract B23: Autoimmune hypophysitis is a marker of favorable outcome during treatment of melanoma with ipilimumab ↗Cancer Research · 2015not yet assessed
-
Abstract B38: Pilot study of combination PSMA peptide and TARP peptide vaccine with poly-IC:LC adjuvant in HLA-A2 positive patients with elevated PSA after initial definitive treatment of prostate cancer ↗Cancer Immunology Research · 2015not yet assessed
-
Abstract 2981: The epithelial to mesenchymal transition (EMT) produces colorectal cancer subpopulations with strikingly different mutation profiles ↗Cancer Research · 2015not yet assessed
-
Abstract B67: Effect of polyphenon E on progression to prostate cancer after diagnosis of high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation in African American men ↗Cancer Epidemiology Biomarkers & Prevention · 2015not yet assessed
-
Effect of green tea catechins in prostate cancer chemoprevention. ↗Journal of Clinical Oncology · 2015not yet assessed
-
Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma ↗Clinical Cancer Research · 2014 · PMID 25524312not yet assessed
-
Influence of Mindfulness-Based Stress Reduction (MBSR) on Telomerase Activity in Women With Breast Cancer (BC) ↗Biological Research For Nursing · 2014 · PMID 24486564not yet assessed
-
Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors ↗Endocrine Related Cancer · 2014 · PMID 25376618not yet assessed
-
A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors ↗Clinical Cancer Research · 2014 · PMID 24429877not yet assessed
-
Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation ↗Acta Oncologica · 2014 · PMID 25549537not yet assessed
-
Baseline Immune Biomarkers as Predictors of MBSR(BC) Treatment Success in Off-Treatment Breast Cancer Patients ↗Biological Research For Nursing · 2014 · PMID 24477514not yet assessed
-
Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing ↗Journal of Clinical Pathology · 2014 · PMID 25004944not yet assessed
-
Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer ↗Oral Oncology · 2014 · PMID 24954065not yet assessed
-
Regular aspirin (ASA) use and survival in patients with PIK3CA-mutated metastatic colorectal cancer (CRC). ↗Journal of Clinical Oncology · 2014not yet assessed
-
Abstract LB-188: Co-evolution of primary and metastatic colorectal cancer ↗Cancer Research · 2014not yet assessed
-
The role of the Caenorhabditis elegans E4 enzyme UFD-2 inDNA damage repair and apoptosis2014not yet assessed
-
SAM Surface Domains of (11-Mercaptooundecyl)-N,N,N-Trimethlyammonium Bromide and Dodecanthiol Mixtures on Au(111) Investigated Via AFMBulletin of the American Physical Society · 2014not yet assessed
-
Structural Properties of Gold Thin Films Deposited on various Substrates by RF Magnetron SputteringBulletin of the American Physical Society · 2014not yet assessed
-
Randomized International Phase III Trial of ERCC1 and RRM1 Expression–Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer ↗Journal of Clinical Oncology · 2013 · PMID 23690416not yet assessed
-
Ubiquitin C-Terminal Hydrolase-L1 Potentiates Cancer Chemosensitivity by Stabilizing NOXA ↗Cell Reports · 2013 · PMID 23499448not yet assessed
-
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms ↗Molecular Systems Biology · 2013 · PMID 24189400not yet assessed
-
Phase II Trial of a GM-CSF-producing and CD40L-expressing Bystander Cell Line Combined With an Allogeneic Tumor Cell–based Vaccine for Refractory Lung Adenocarcinoma ↗Journal of Immunotherapy · 2013 · PMID 23994887not yet assessed
-
Cetuximab with or without sorafenib in recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN). ↗Journal of Clinical Oncology · 2013not yet assessed
-
Molecular analysis-directed, international, phase III trial in patients with advanced non-small-cell lung cancer. ↗Journal of Clinical Oncology · 2013not yet assessed
-
Association of aspirin use with improved 5-year survival in colorectal cancer patients with PIK3CA mutation. ↗Journal of Clinical Oncology · 2013not yet assessed
-
Structural Properties of Gold Thin Films Deposited on Technologically Important Substrates by Magnetron SputteringBulletin of the American Physical Society · 2013not yet assessed
-
Study of Hydrogen flame annealed Au thin-film surface morphology, integrity and film quality on various substrate surfacesBulletin of the American Physical Society · 2013not yet assessed
-
A phase II study of RO4929097 in metastatic colorectal cancer ↗European Journal of Cancer · 2012 · PMID 22445247not yet assessed
-
Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization ↗Bone Marrow Transplantation · 2012 · PMID 22863723not yet assessed
-
A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors ↗Annals of Oncology · 2012 · PMID 22317769not yet assessed
-
Expression of CXCR4, E-Cadherin, Bcl-2, and Survivin in Merkel Cell Carcinoma ↗American Journal of Dermatopathology · 2012 · PMID 22814318not yet assessed
-
Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers ↗Cancer · 2012 · PMID 23065656not yet assessed
-
Phase II trial of a GM-CSF-producing and CD40L-expressing cell line combined with allogeneic tumor antigen as a novel vaccine for metastatic lung adenocarcinoma. ↗Journal of Clinical Oncology · 2012not yet assessed
-
Effectiveness of Unrelated Donor Allogeneic Hematopoietic Cell Transplantation: Results of a Donor Vs. No Donor Analysis ↗Transplantation and Cellular Therapy · 2012not yet assessed
-
How to run survival-endpoint phase II trials with 25% to 40% fewer patients. ↗Journal of Clinical Oncology · 2012not yet assessed
-
Assessment of feasibility and willingness of former heavy smokers to participate in chemoprevention trials to prevent lung cancer. ↗Journal of Clinical Oncology · 2012not yet assessed
-
ID1 Facilitates the Growth and Metastasis of Non-Small Cell Lung Cancer in Response to Nicotinic Acetylcholine Receptor and Epidermal Growth Factor Receptor Signaling ↗Molecular and Cellular Biology · 2011 · PMID 21606196not yet assessed
-
ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis ↗American Journal Of Pathology · 2011 · PMID 21224045not yet assessed
-
Preliminary indication of survival benefit from ERCC1 and RRM1‐tailored chemotherapy in patients with advanced nonsmall cell lung cancer: Evidence from an individual patient analysis ↗Cancer · 2011 · PMID 22028294not yet assessed
-
Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer ↗Contemporary Clinical Trials · 2011 · PMID 22101219not yet assessed
-
Phase II Multicenter Trial of Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer ↗International Journal of Radiation Oncology*Biology*Physics · 2011not yet assessed
-
Abstract 4993: Nicotine induced EMT and metastasis of human NSCLC : Role of beta-arrestin-1 ↗Cancer Research · 2011not yet assessed
-
Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non–Small-Cell Lung Cancer ↗Journal of Clinical Oncology · 2010 · PMID 20142592not yet assessed
-
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: Leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma ↗International Journal of Cancer · 2010 · PMID 21154746not yet assessed
-
Suicide in patients with pancreatic cancer ↗Cancer · 2010 · PMID 20824626not yet assessed
-
Optimism bias leads to inconclusive results—an empirical study ↗Journal of Clinical Epidemiology · 2010 · PMID 21163620not yet assessed
-
The False Discovery Rate: A Key Concept in Large-Scale Genetic Studies ↗Cancer Control · 2010 · PMID 20010520not yet assessed
-
Features of Potentially Predictive Biomarkers of Chemotherapeutic Efficacy in Small Cell Lung Cancer ↗Journal of Thoracic Oncology · 2010 · PMID 20107425not yet assessed
-
Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survival ↗Annals of Hematology · 2010 · PMID 21153898not yet assessed
-
Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer ↗Journal of Clinical Oncology · 2009 · PMID 19884554not yet assessed
-
Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells ↗Cancer Biology & Therapy · 2009 · PMID 19633423not yet assessed
-
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD ↗Bone Marrow Transplantation · 2009 · PMID 19684623not yet assessed
-
Analysis of Group Randomized Trials with Multiple Binary Endpoints and Small Number of Groups ↗PLoS ONE · 2009 · PMID 19844579not yet assessed
-
In SituProtein Expression of RRM1, ERCC1, and BRCA1 in Metastatic Breast Cancer Patients Treated with Gemcitabine-Based Chemotherapy ↗Cancer Investigation · 2009 · PMID 19968494not yet assessed
-
A Randomized, Controlled Trial of Graft-Versus-Host Disease (GVHD) Prophylaxis Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate: Analysis of GVHD, Relapse and Survival ↗Transplantation and Cellular Therapy · 2009not yet assessed
-
Autologous Stem Cell Transplantation (ASCT) In Patients Aged ≥65 Years With Multiple Myeloma: Moffitt Cancer Center Experience ↗Transplantation and Cellular Therapy · 2009not yet assessed
-
Evidence for long-term survival in a sizeable proportion of good performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC) ↗Journal of Clinical Oncology · 2009not yet assessed
-
Outcomes of Adrenalectomy for Isolated Synchronous Versus Metachronous Adrenal Metastases in Non–Small-Cell Lung Cancer: A Systematic Review and Pooled Analysis ↗Journal of Clinical Oncology · 2008 · PMID 18309950not yet assessed
-
Thymidylate synthase in situ protein expression and survival in stage I nonsmall‐cell lung cancer ↗Cancer · 2008 · PMID 18442042not yet assessed
-
Relationship of gliomas to the ventricular walls ↗Journal of Clinical Neuroscience · 2008 · PMID 19097905not yet assessed
-
Phase 2 trial of docetaxel and gefitinib in the first‐line treatment of patients with advanced nonsmall‐cell lung cancer (NSCLC) who are 70 years of age or older ↗Cancer · 2008 · PMID 18300255not yet assessed
-
Sample size selection in clinical trials when population means are subject to a partial order: one-sided ordered alternatives ↗Journal of Applied Statistics · 2008 · PMID 40538985not yet assessed
-
not yet assessed
-
A Predictive Risk Probability Approach for Microarray Data with Survival as an Endpoint ↗Journal of Biopharmaceutical Statistics · 2008 · PMID 18781520not yet assessed
-
not yet assessed
-
Predictive value of RRM1 and ERCC1 protein levels in a prospective community-based trial of gemcitabine/carboplatin (GC) vs gemcitabine (G) alone ↗Journal of Clinical Oncology · 2008not yet assessed
-
not yet assessed
-
Comparison of Three Methods to Increase Knowledge About Breast Cancer and Breast Cancer Screening in Screening Mammography Patients ↗Academic Radiology · 2007 · PMID 17434069not yet assessed
-
Bystander-Based Immunotherapy for Patients with Mantle Cell Lymphoma (MCL): Proof of Principle. ↗Blood · 2007not yet assessed
-
not yet assessed
-
Immunohistochemistry for D-serine in brain2007not yet assessed
-
ABCG2 expression, function, and promoter methylation in human multiple myeloma ↗Blood · 2006 · PMID 16917002not yet assessed
-
Continuous Toxicity Monitoring in Phase II Trials in Oncology ↗Biometrics · 2005 · PMID 16011702not yet assessed
-
Carboplatin-based chemotherapy in patients with advanced non-small cell lung cancer and a poor performance status ↗Lung Cancer · 2005 · PMID 16378657not yet assessed
-
Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately High to Highly Emetogenic Chemotherapy ↗American Journal of Clinical Oncology · 2005 · PMID 15923800not yet assessed
-
CHAPTER 8. Hit . . . and Run Adjusting Double and Triple Totals ↗Princeton University Press eBooks · 2005not yet assessed
-
413: Androgen Tissue Levels in Recurrent Prostate Cancer using Liquid Chromatography Tandem Mass Spectrometry ↗The Journal of Urology · 2005not yet assessed
-
Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer ↗Lung Cancer · 2004 · PMID 15639724not yet assessed
-
[Case report: lymphosarcoma in a cow]. ↗PubMed · 2004 · PMID 14983754not yet assessed
-
836: Racial Differences in Prostate Androgen Levels in Men with Clinically Localized Prostate Cancer ↗The Journal of Urology · 2004not yet assessed
-
The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel ↗Cancer · 2003 · PMID 12910523not yet assessed
-
Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer ↗Lung Cancer · 2003 · PMID 12660013not yet assessed
-
Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women,, ↗American Journal of Clinical Nutrition · 2002 · PMID 12399289not yet assessed
-
Phase III Trial Comparing a Defined Duration of Therapy Versus Continuous Therapy Followed by Second-Line Therapy in Advanced-Stage IIIB/IV Non–Small-Cell Lung Cancer ↗Journal of Clinical Oncology · 2002not yet assessed
-
Second‐line, low‐dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first‐line chemotherapy with carboplatin plus paclitaxel ↗Cancer · 2002 · PMID 12216094not yet assessed
-
Influence of Serum and Tissue Micronutrient Levels on the Regression of Untreated Cervical Intraepithelial Neoplasia 2 and 3 ↗Journal of Lower Genital Tract Disease · 2002 · PMID 17051026not yet assessed
-
The association of race/ethnicity, socioeconomic status, and physician recommendation for mammography: who gets the message about breast cancer screening? ↗American Journal of Public Health · 2001 · PMID 11189825not yet assessed
-
Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma ↗Cancer · 2001 · PMID 11571735not yet assessed
-
A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia. ↗PubMed · 2001 · PMID 11588128not yet assessed
-
Retrospective classification of prostate-specific antigen tests: ↗Journal of Clinical Epidemiology · 2001 · PMID 11520647not yet assessed
-
Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research Program. ↗PubMed · 2001 · PMID 11641020not yet assessed
-
Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation ↗Transplantation and Cellular Therapy · 2000 · PMID 10975512not yet assessed
-
A Population-Based Case-Control Study of Farming and Breast Cancer in North Carolina ↗Epidemiology · 2000 · PMID 10955404not yet assessed
-
Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose‐escalating conformal thoracic radiation therapy in unresectable Stage IIIA/B nonsmall cell lung carcinoma ↗Cancer · 2000 · PMID 10931452not yet assessed
-
Second-Line Gemcitabine in Refractory Stage IV Non–Small-Cell Lung Cancer: A Phase II Trial ↗Clinical Lung Cancer · 2000 · PMID 14731324not yet assessed
-
Second-line (SL) weekly paclitaxel (P) in patients (pts) with advanced non-small cell lung cancer (NSCLC) failing first-line (FL) carboplatin/paclitaxel (C/P) ↗Lung Cancer · 2000not yet assessed
-
not yet assessed
-
not yet assessed
-
Adjusted Odds Ratios Under Nondifferential Misclassification ↗Journal of Clinical Epidemiology · 1999 · PMID 10201653not yet assessed
-
Bridging Different Eras in Sports: Comment ↗Journal of the American Statistical Association · 1999not yet assessed
-
Comment ↗Journal of the American Statistical Association · 1999not yet assessed
-
Screening behavior of women after a false-positive mammogram. ↗Radiology · 1998 · PMID 9646820not yet assessed
-
In vitro percutaneous absorption of boron as boric acid, borax, and disodium octaborate tetrahydrate in human skin ↗Biological Trace Element Research · 1998not yet assessed
-
Adjuvant Chemotherapy for Resected Non‐Small Cell Carcinoma of the Lung: Why We Still Don't Know ↗The Oncologist · 1998 · PMID 10388082not yet assessed
-
Validation of a model predicting enrollment status in a chemoprevention trial for breast cancer. ↗PubMed · 1998 · PMID 9681527not yet assessed
-
RESTORATION OF ORAL ALL-TRANS RETINOIC ACID BIOAVAILABILITY AFTER A BRIEF DRUG HOLIDAY ↗American Journal of Therapeutics · 1997 · PMID 10423603not yet assessed
-
128 Five year results for linac radiosurgery for arteriovenous malformations: Poor outcome for large AVMs ↗International Journal of Radiation Oncology*Biology*Physics · 1997not yet assessed
-
beta-Carotene treatment of cervical intraepithelial neoplasia: a phase II study. ↗PubMed · 1996 · PMID 8922303not yet assessed
-
Effects of diverse laser parameters at 9.3 μm on soft tissue and bone ↗Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 1996not yet assessed
-
149 The long term effects of high dose rate brachytherapy on neointimal hyperplasia formation in the rat carotid artery — An update ↗International Journal of Radiation Oncology*Biology*Physics · 1996not yet assessed
-
Factors Associated with Postoperative Pulmonary Complications in Patients with Severe Chronic Obstructive Pulmonary Disease ↗Anesthesia & Analgesia · 1995 · PMID 7818113not yet assessed
-
Factors Associated with Postoperative Pulmonary Complications in Patients with Severe Chronic Obstructive Pulmonary Disease ↗Anesthesia & Analgesia · 1995not yet assessed
-
Effect of ND:YAG Laser Irradiation and Root Planing on the Root Surface: Structural and Thermal Effects ↗Journal of Periodontology · 1995 · PMID 8683415not yet assessed
-
Factors Associated with Postoperative Pulmonary Complications in Patients with Severe Chronic Obstructive Pulmonary Disease ↗Survey of Anesthesiology · 1995not yet assessed
-
Effect of freezing on the relative escape force of sperm as measured by a laser optical trap ↗Fertility and Sterility · 1995 · PMID 7805910not yet assessed
-
Approximations to the powers of the likelihood ratio tests: the loop ordering and slippage alternatives ↗Communications in Statistics - Simulation and Computation · 1995not yet assessed
-
2013 Analysis of toxicity in a group of patients treated for pancreatic cancer with combined modality 3D radiation therapy ↗International Journal of Radiation Oncology*Biology*Physics · 1995not yet assessed
-
A comparison of the prognoses for deep and subcutaneous sarcomas of the extremities. ↗Journal of Bone and Joint Surgery · 1994 · PMID 8056797not yet assessed
-
Primary Vaginal Melanoma: Improved Survival with Radical Pelvic Surgery ↗Gynecologic Oncology · 1994 · PMID 7959290not yet assessed
-
Differential Vascular Response to Laser Photothermolysis ↗Journal of Investigative Dermatology · 1994 · PMID 7963659not yet assessed
-
Photodynamic destruction of endometrial tissue with topical 5-aminolevulinic acid in rats and rabbits ↗American Journal of Obstetrics and Gynecology · 1994 · PMID 7977515not yet assessed
-
Laser photothermolysis of single blood vessels in the chick chorioallantoic membrane (CAM) ↗Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 1994not yet assessed
-
The power functions of the likelihood ratio tests for a simple tree ordering in normal means: unequal weights ↗Communication in Statistics- Theory and Methods · 1993not yet assessed
-
The contributions of patient factors, physician delay, and tumor biology to the outcome of gastric cancer. ↗PubMed · 1993 · PMID 8256942not yet assessed
-
On power functions of the likelihood ratio tests for the simple loop order in normal means: Unequal sample sizes ↗Statistics & Probability Letters · 1992not yet assessed
-
Successful Intermittent Chemoprophylaxis forPneumocystis cariniiPneumonitis ↗New England Journal of Medicine · 1987 · PMID 3495732not yet assessed
-
Robustness of $${\overline {\rm{\chi }} ^2}$$ and $${\overline {\rm{E}} ^2}$$ : A Case for a Ranked Test in Order-Restricted Inference ↗Lecture notes in statistics · 1986not yet assessed
-
Treatment experience: Locally advanced sarcomas with 15 MeV fast neutrons ↗Cancer · 1980 · PMID 6769582not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
Merged across profiles sharing this ORCID where present. See every “Schell M” paper on PubMed ↗